A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Status:
Completed
Trial end date:
2016-04-19
Target enrollment:
Participant gender:
Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center,
parallel group study comparing remimazolam to placebo, with an additional open-label arm for
midazolam, in patients undergoing a colonoscopy for diagnostic or therapeutic reasons.